Illness presentation and quality of life in myalgic encephalomyelitis/chronic fatigue syndrome and post COVID-19 condition: a pilot Australian cross-sectional study
Open Access
- 3 July 2024
- journal article
- research article
- Published by Springer Nature in Quality of Life Research
- Vol. 33 (9) , 2489-2507
Abstract
Purpose: Post COVID-19 Condition (PCC), being persistent COVID-19 symptoms, is reminiscent of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)—a chronic multi-systemic illness characterised by neurocognitive, autonomic, endocrinological and immunological disturbances. This novel cross-sectional investigation aims to: (1) compare symptoms among people with ME/CFS (pwME/CFS) and people with PCC (pwPCC) to inform developing PCC diagnostic criteria; and (2) compare health outcomes between patients and people without acute or chronic illness (controls) to highlight the illness burdens of ME/CFS and PCC. Methods: Sociodemographic and health outcome data were collected from n = 61 pwME/CFS, n = 31 pwPCC and n = 54 controls via validated, self-administered questionnaires, including the 36-Item Short-Form Health Survey version 2 (SF-36v2) and World Health Organization Disability Assessment Schedule version 2.0 (WHODAS 2.0). PwME/CFS and pwPCC also provided self-reported severity and frequency of symptoms derived from the Canadian and International Consensus Criteria for ME/CFS and the World Health Organization case definition for PCC. Results: Both illness cohorts similarly experienced key ME/CFS symptoms. Few differences in symptoms were observed, with memory disturbances, muscle weakness, lymphadenopathy and nausea more prevalent, light-headedness more severe, unrefreshed sleep more frequent, and heart palpitations less frequent among pwME/CFS (all p < 0.05). The ME/CFS and PCC participants’ SF-36v2 or WHODAS 2.0 scores were comparable (all p > 0.05); however, both cohorts returned significantly lower scores in all SF-36v2 and WHODAS 2.0 domains when compared with controls (all p < 0.001). Conclusion: This Australian-first investigation demonstrates the congruent and debilitating nature of ME/CFS and PCC, thereby emphasising the need for multidisciplinary care to maximise patient health outcomes.Keywords
Funding Information
- Stafford Fox Medical Research Foundation (489798)
- National Health and Medical Research Council (1199502)
- Mason Foundation (47107)
- McCusker Charitable Foundation (49979)
- Ian and Talei Stewart
- Buxton Foundation (4676)
- Henty Community (4879)
- Mr Douglas Stutt
- Blake Beckett Trust Foundation (4579)
- Alison Hunter Memorial Foundation (4570)
- Change for ME Charity (4575)
- Griffith University
This publication has 92 references indexed in Scilit:
- What Long COVID investigators can learn from four decades of ME/CFS researchBrain Behavior and Immunity Integrative, 2023
- People with Long Covid and ME/CFS Exhibit Similarly Impaired Balance and Physical Capacity: A Case-Case-Control StudyThe American Journal of Medicine, 2023
- Development of a Definition of Postacute Sequelae of SARS-CoV-2 InfectionJAMA, 2023
- Post-COVID-19 condition is not only a question of persistent symptoms: structured screening including health-related quality of life reveals two separate clusters of post-COVIDInfection, 2022
- Postural balance and its association with functionality and quality of life in non‐hospitalized patients with post‐acute COVID‐19 syndromePhysiotherapy Research International, 2022
- Volumetric differences in hippocampal subfields and associations with clinical measures in myalgic encephalomyelitis/chronic fatigue syndromeJournal of Neuroscience Research, 2022
- Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19JAMA Network Open, 2021
- Cytomegalovirus, Epstein‐Barr virus, and human herpesvirus‐6 infections in patients with myalgic еncephalomyelitis/chronic fatigue syndromeJournal of Medical Virology, 2020
- Health-related quality of life in patients with myalgic encephalomyelitis/chronic fatigue syndrome: an Australian cross-sectional studyQuality of Life Research, 2020
- World Medical Association Declaration of HelsinkiJAMA, 2013